Hester Biosciences Announcements
Newspaper Clippings of Financial Results
31 Jan, 2026 | 10:37am • Source: BSE
Pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the audio recording of the...
30 Jan, 2026 | 03:32pm • Source: BSE
20260130 Press Release Q3 FY26
30 Jan, 2026 | 11:43am • Source: BSE
Financial Results for the period ended 31 December 2025
30 Jan, 2026 | 11:34am • Source: BSE
Outcome of Board Meeting held on 30 January 2026
30 Jan, 2026 | 11:27am • Source: BSE
20260124 Press Release - Hester receives manufacturing license for Inactivated Avian Influenza Vaccine for poultry
24 Jan, 2026 | 05:07pm • Source: BSE
This is to inform you that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the...
23 Jan, 2026 | 02:11pm • Source: BSE
Hester Biosciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
08 Jan, 2026 | 01:23pm • Source: NSE
Confirmation Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended 31 December 2025
08 Jan, 2026 | 12:06pm • Source: BSE
Hester Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
30 Dec, 2025 | 10:27am • Source: NSE
Closure of Trading Window for the Financial Results
30 Dec, 2025 | 09:16am • Source: BSE
Hester Biosciences Limited has informed the Exchange about Change in KMPs Authorisation under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
20 Nov, 2025 | 10:04am • Source: NSE
Hester Biosciences Limited has informed the Exchange about Outcome of Resolution passed by the Board of Directors by Circulation - Appointment of Chief Financial Officer...
20 Nov, 2025 | 10:02am • Source: NSE
Transcripts of earnings conference call held on 12 November 2025
14 Nov, 2025 | 05:01pm • Source: BSE
Intimation regarding speech of Ms. Priya Gandhi, Executive Director of the Company at the Q2 & H1 FY 2025-26 earnings Conference Call held on 12...
12 Nov, 2025 | 03:35pm • Source: BSE
Pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the audio recording of the...
12 Nov, 2025 | 03:30pm • Source: BSE
Hester Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025
12 Nov, 2025 | 12:31pm • Source: NSE
20251112 Q2 & H1 FY26 Press Release on Financial Results
12 Nov, 2025 | 11:42am • Source: BSE
Financial Results for the period ended 30 September 2025
12 Nov, 2025 | 11:35am • Source: BSE
Outcome of Board Meeting held today
12 Nov, 2025 | 11:29am • Source: BSE